1Ford A, Delaney B, Forman D, et al. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst Rev ,2004,4 : CD003840.
2Gisbert JP,Khorrami S, Catballo F, et al. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Database Syst Rev,2004,2 : CD004062.
4Lu H ,Hsu PI,Graham DY,et al. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology,2005,128 : 833-848.
5de Jonge R, Kuipers EJ, Langeveld SC, et al. The Helicobacter pylori plasticity region locus jhpO947-jhp0949 is associated with duodenal ulcer disease and interleukin-12 production in monocyte cells. FEMS Immunol Med Microbiol,2004,41:161-167.
6Raghunath A, Hungin APS,Wooff D, et al. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease : systematic review. Br Med J,2003,326:737-739.
8El-Scrag HB,Sonnenberg A,Jamal MM,et al. Corpus gastritis is protective against reflux oesophagitis. Gut, 1999,45 : 181-185.
9Axon AT. Personal view: to treat or not to treat? Helicobacter pylori and gastro-oesophageal reflux disease - an alternative hypothesis. Aliment Pharmacol Ther,2004,19 :253-261.
10Raghunath AS, Hungin AP, Wooff D, et al. Systematic review : the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux ocsophagitis. Aliment Pharmacol Ther,2004,20:733-744.
二级参考文献29
1El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998,43:327-333.
2Pera M,Cameron AJ,Trastek VF,et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology, 1993,104:510-513.
3Weston AP, Badr AS, Topalovski M, et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett′s esophagus, Barrett′s dysplasia, and Barrett′s adenocarcinoma. Am J Gastroenterol,2000,95:387-394.
4Schenk BE, Kuipers EJ, Klinkenberg-Knol EC,et al. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. J Gastroenterol,1999,94:884-887.
5Wu JC, Sung JJ, Chan FK, et al. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease. Aliment Pharmacol Ther,2000 ; 14: 427-432.
6Labenz J, Blum AL, Bayerdrffer E, et al. Curing helicobacter pylori infection in patints with duodenal ulcer may provoke reflux esophagitis. Gastroenterology,1997,112:1442-1447.
7Fallone CA,Barkun AN,Friedman G,et al. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease. Am J Gastroenterol,2000,95: 914-920.
8Hamada H, Haruma K, Mihara M, et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatus hernia and corpus gastritis. Aliment Pharmacol Ther, 2000,14:729-735.
9Tepes B, Kavcic B, Gubina M, et al. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication. Hepatogastroenterology, 1999,46: 1746-1750.
10Feldman M,Cryer B,Sammer D,et al. Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. Am J Physiol, 1999, 277(6 Pt 1):G1159-1164.
